Breaking: Tyson Foods Q3 Misses Mark; Ginkgo Bioworks' Merck Deal Shakes Up
- August 07th, 2023
- 412 views
Tyson Foods, Inc. (NYSE: TSN) has released its third-quarter fiscal 2023 financial results, reporting adjusted earnings per share (EPS) of $0.15 and revenues totaling $13.14 billion. These figures fell short of market consensus estimates of $0.26 EPS on revenues of $13.59 billion.
$TSN was trading at $52.67 in pre-market, down $3.79 (-6.71%).
In other news, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has unveiled a strategic partnership with Merck & Co., Inc. (NYSE: MRK).
The collaboration agreement, which marks the second between the companies and is aimed at improving biologic manufacturing, outlines the potential for Ginkgo to receive up to $490 million, encompassing upfront research fees, milestones, and commercial payments.
In pre-market, $DNA was trading at $2.18, reflecting an increase of $0.14 (+6.86%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
February 27th, 2026February 26th, 2026
Treasury Sanctions Nicaraguan Officials Enabling the Murillo-Ortega Dictatorship's Repression
February 26th, 2026Kansas City Storm Names Cecil Stockdale as Head Coach for 2026 NJCP Season
February 26th, 2026Dallas Stampede Announces Open Tryouts for Scholarship Opportunities
February 25th, 2026
Member Login